Maximizing HER2+ Primary Tumor Killing Through Various APIs, Methods of Drug Delivery & Immune System Engagement
Testing Next Generation Therapeutics & Combinations for Specific Non-Breast HER2 Expressing Gut, Bowel and Lung Tumors With Well-Designed Indication-Agnostic Trials
Utilizing Late Stage Development Data for Improved Targeting & Combination Partner Selection
Hitting Moving Targets – Approaches to Treating HER2+ Metastases
Afternoon Refreshment Break
Past Events
HER2-Targeted Therapies Summit 2023 - 30 Oct - 01 Nov, 2023, Boston, Massachusetts, United States (92340)
Important
Please, check "HER2-Targeted Therapies Summit" official website for possible changes, before making any traveling arrangements
